LEUKOERYTHROBLASTOSIS

This adverse event was reported 100 times

These drugs are most commonly taken by patients reporting LEUKOERYTHROBLASTOSIS:

# Drug Count
0 METHOTREXATE SODIUM 49
1 METHOTREXATE 46
2 RITUXIMAB 31
3 CYCLOPHOSPHAMIDE 25
4 CYCLOPHOSPHAMIDE FOR INJECTION 25
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 25
6 DOXORUBICIN 23
7 ETOPOSIDE 23
8 FLUDARABINE PHOSPHATE 22
9 CYTARABINE 21
See all common drugs associated with LEUKOERYTHROBLASTOSIS

LEUKOERYTHROBLASTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAFENOQUINE SUCCINATE 2 0.1818
1 DAUNORUBICIN HYDROCHLORIDE 10 0.0061
2 IDARUBICIN HYDROCHLORIDE 2 0.0017
3 ATOVAQUONE AND PROGUANIL HYDROCHLORIDE 2 0.0009
4 IFOSFAMIDE FOR INJECTION 19 0.0009
5 CALCIUM FOLINATE 4 0.0008
6 RIFABUTIN 2 0.0007
7 VINCRISTINE SULFATE 17 0.0006
8 FLUDARABINE PHOSPHATE 22 0.0006
9 ROMIPLOSTIM 7 0.0005
See all drugs enriched for association with LEUKOERYTHROBLASTOSIS

LEUKOERYTHROBLASTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Rifamycin Antimycobacterial [EPC] 2 0.0006
1 Thrombopoietin Receptor Agonist [EPC] 7 0.0005
2 Erythroid Maturation Agent [EPC] 1 0.0004
3 Sulfone [EPC] 4 0.0004
4 Topoisomerase Inhibitor [EPC] 23 0.0003
5 Antimalarial [EPC] 2 0.0002
6 Antiprotozoal [EPC] 2 0.0002
7 Alkylating Drug [EPC] 29 0.0001
8 Alkaloid [EPC] 3 0.0001
9 Folate Analog Metabolic Inhibitor [EPC] 46 0.0001
See all drug classes enriched for association with LEUKOERYTHROBLASTOSIS